Search

Your search keyword '"Brennan CW"' showing total 50 results

Search Constraints

Start Over You searched for: Author "Brennan CW" Remove constraint Author: "Brennan CW" Search Limiters Available in Library Collection Remove constraint Search Limiters: Available in Library Collection
50 results on '"Brennan CW"'

Search Results

2. Modeling lung adenocarcinoma metastases using patient-derived organoids.

Catalog

Books, media, physical & digital resources

3. Outcomes Following Early Postoperative Adjuvant Radiosurgery for Brain Metastases.

4. Integrated analysis of single-cell chromatin state and transcriptome identified common vulnerability despite glioblastoma heterogeneity.

5. PRMT6 methylation of RCC1 regulates mitosis, tumorigenicity, and radiation response of glioblastoma stem cells.

6. Defining phenotypic and functional heterogeneity of glioblastoma stem cells by mass cytometry.

7. Durable 5-year local control for resected brain metastases with early adjuvant SRS: the effect of timing on intended-field control.

8. Development of a gene expression-based prognostic signature for IDH wild-type glioblastoma.

9. Genetic and epigenetic landscape of IDH-wildtype glioblastomas with FGFR3-TACC3 fusions.

10. LY6K promotes glioblastoma tumorigenicity via CAV-1-mediated ERK1/2 signaling enhancement.

11. Cell Lineage-Based Stratification for Glioblastoma.

12. Use of the Omental Free Flap for Treatment of Chronic Anterior Skull Base Infections.

13. Temporal Lobe Necrosis in Head and Neck Cancer Patients after Proton Therapy to the Skull Base.

14. Ultrasmall Core-Shell Silica Nanoparticles for Precision Drug Delivery in a High-Grade Malignant Brain Tumor Model.

15. Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas.

16. Human Mesenchymal glioblastomas are characterized by an increased immune cell presence compared to Proneural and Classical tumors.

17. CHD4 regulates the DNA damage response and RAD51 expression in glioblastoma.

18. Tracking tumour evolution in glioma through liquid biopsies of cerebrospinal fluid.

19. Incidence of Prolonged Systemic Steroid Treatment after Surgery for Acoustic Neuroma and Its Implications.

20. Metabolic Imaging of the Human Brain with Hyperpolarized 13 C Pyruvate Demonstrates 13 C Lactate Production in Brain Tumor Patients.

21. Clinicians' perceptions of usefulness of the PubMed4Hh mobile device application for clinical decision making at the point of care: a pilot study.

22. Genome-wide methylomic and transcriptomic analyses identify subtype-specific epigenetic signatures commonly dysregulated in glioma stem cells and glioblastoma.

23. Integrating Proteomics and Transcriptomics for Systematic Combinatorial Chimeric Antigen Receptor Therapy of AML.

24. Multicenter phase II study of temozolomide and myeloablative chemotherapy with autologous stem cell transplant for newly diagnosed anaplastic oligodendroglioma.

25. EGFR and PDGFRA co-expression and heterodimerization in glioblastoma tumor sphere lines.

26. Macrophage Ontogeny Underlies Differences in Tumor-Specific Education in Brain Malignancies.

27. Organization of nursing and quality of care for veterans at the end of life.

28. Sleeping Beauty mouse models identify candidate genes involved in gliomagenesis.

29. Phase II study of bevacizumab, temozolomide, and hypofractionated stereotactic radiotherapy for newly diagnosed glioblastoma.

30. Transcriptional diversity of long-term glioblastoma survivors.

31. Loss of the tyrosine phosphatase PTPRD leads to aberrant STAT3 activation and promotes gliomagenesis.

32. Suppression of microRNA-9 by mutant EGFR signaling upregulates FOXP1 to enhance glioblastoma tumorigenicity.

33. The somatic genomic landscape of glioblastoma.

34. CSF-1R inhibition alters macrophage polarization and blocks glioma progression.

35. Double minute chromosomes in glioblastoma multiforme are revealed by precise reconstruction of oncogenic amplicons.

36. Tumor-infiltrating lymphocytes in glioblastoma are associated with specific genomic alterations and related to transcriptional class.

37. A survey of intragenic breakpoints in glioblastoma identifies a distinct subset associated with poor survival.

38. MEF promotes stemness in the pathogenesis of gliomas.

39. Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma.

40. A brain tumor molecular imaging strategy using a new triple-modality MRI-photoacoustic-Raman nanoparticle.

41. Intratumoral heterogeneity of receptor tyrosine kinases EGFR and PDGFRA amplification in glioblastoma defines subpopulations with distinct growth factor response.

42. Genomic dissection of the epidermal growth factor receptor (EGFR)/PI3K pathway reveals frequent deletion of the EGFR phosphatase PTPRS in head and neck cancers.

43. Splicing factor hnRNPH drives an oncogenic splicing switch in gliomas.

44. Loss of ATM/Chk2/p53 pathway components accelerates tumor development and contributes to radiation resistance in gliomas.

45. PDGFRA gene rearrangements are frequent genetic events in PDGFRA-amplified glioblastomas.

46. Perivascular nitric oxide activates notch signaling and promotes stem-like character in PDGF-induced glioma cells.

47. PTEN/PI3K/Akt pathway regulates the side population phenotype and ABCG2 activity in glioma tumor stem-like cells.

48. Assessment of the language laterality index in patients with brain tumor using functional MR imaging: effects of thresholding, task selection, and prior surgery.

49. Isolated translocation of Wernicke's area to the right hemisphere in a 62-year-man with a temporo-parietal glioma.

50. Array comparative genome hybridization for tumor classification and gene discovery in mouse models of malignant melanoma.